- Home
- MDGL vs AXTA Comparison
MDGL vs AXTA Comparison
Compare MDGL & AXTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- AXTA
- Stock Information
- Founded
- MDGL 2011
- AXTA 1910
- Country
- MDGL United States
- AXTA United States
- Employees
- MDGL N/A
- AXTA N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- AXTA Paints/Coatings
- Sector
- MDGL Health Care
- AXTA Consumer Discretionary
- Exchange
- MDGL Nasdaq
- AXTA Nasdaq
- Market Cap
- MDGL 6.8B
- AXTA 7.2B
- IPO Year
- MDGL N/A
- AXTA 2014
- Fundamental
- Price
- MDGL $267.56
- AXTA $32.66
- Analyst Decision
- MDGL Strong Buy
- AXTA Buy
- Analyst Count
- MDGL 10
- AXTA 15
- Target Price
- MDGL $420.63
- AXTA $41.33
- AVG Volume (30 Days)
- MDGL 367.0K
- AXTA 2.8M
- Earning Date
- MDGL 05-01-2025
- AXTA 05-07-2025
- Dividend Yield
- MDGL N/A
- AXTA N/A
- EPS Growth
- MDGL N/A
- AXTA 83.38
- EPS
- MDGL N/A
- AXTA 2.05
- Revenue
- MDGL $317,383,000.00
- AXTA $5,244,000,000.00
- Revenue This Year
- MDGL $285.43
- AXTA $2.45
- Revenue Next Year
- MDGL $63.77
- AXTA $3.37
- P/E Ratio
- MDGL N/A
- AXTA $15.11
- Revenue Growth
- MDGL N/A
- AXTA 0.96
- 52 Week Low
- MDGL $200.63
- AXTA $27.70
- 52 Week High
- MDGL $377.46
- AXTA $41.66
- Technical
- Relative Strength Index (RSI)
- MDGL 31.79
- AXTA 52.43
- Support Level
- MDGL $281.76
- AXTA $30.89
- Resistance Level
- MDGL $295.60
- AXTA $33.06
- Average True Range (ATR)
- MDGL 12.60
- AXTA 0.85
- MACD
- MDGL -2.58
- AXTA 0.11
- Stochastic Oscillator
- MDGL 3.22
- AXTA 63.44
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About AXTA Axalta Coating Systems Ltd.
Axalta Coating Systems Ltd is a manufacturer, marketer and distributor of high-performance coatings systems. It operates in two segments, The Performance Coatings segment provides liquid and powder coatings solutions to a fragmented and local customer base. Its end markets include refinish and industrial. The Mobility Coatings segment relates to the provision of coating technologies to original equipment manufacturers of light and commercial vehicles. The company operates in the geographic areas of North America, EMEA countries, Asia-Pacific, and Latin America.